Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rigetti Computing is a pioneer in full-stack quantum computing, specializing in the design and manufacture of integrated quantum circuits and the software platforms required to operate them. The company operates Fab-1, the world's first dedicated and integrated quantum device manufacturing facility, where it produces superconducting quantum processors. In the life sciences and healthcare sectors, Rigetti provides high-performance computational resources for molecular simulation, protein folding analysis, and drug discovery through its Quantum Cloud Services (QCS). By utilizing hybrid quantum-classical algorithms, the company enables pharmaceutical researchers to model complex chemical systems that are beyond the reach of traditional classical computers. Rigetti's technology aims to significantly reduce the time and cost associated with identifying novel therapeutic candidates and optimizing molecular structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rigetti Computing.